Hasil Pencarian (2)
biotech | CAS: 1211327-92-2
Multiple Sclerosis (MS) is a chronic and inflammatory autoimmune disease of the central nervous system, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms…
Kategori:
Adjuvants, ImmunologicAmino Acids, Peptides, and ProteinsAntineoplastic and Immunomodulating Agents
+13
Target Protein:
Interferon alpha/beta receptor 1
Waktu ParuhThe mean half life …
Vol. DistribusiThe volume of distr…
KlirensThe average steady …
Genetik
-
small molecule | CAS: 1230487-00-9
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 [L5792] and by Health Canada on February 20, 2020.[L12171] This drug is considered a _sphingo…
Kategori:
Agents that produce hypertensionAntineoplastic and Immunomodulating AgentsAzetines
+18
Target Protein:
Sphingosine 1-phosphate receptor 1Sphingosine 1-phosphate receptor 5
Waktu ParuhThe apparent elimin…
Vol. DistribusiSiponimod distribut…
KlirensApparent systemic c…
Genetik
-